Skip to content

Effects of dezocine on the tatio of Th1/Th2 in patients undergoing laparoscopic radical gastrectomy during postoperative analgesia

Effects of dezocine on the tatio of Th1/Th2 in patients undergoing laparoscopic radical gastrectomy during postoperative analgesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000033754
Enrollment
Unknown
Registered
2020-06-11
Start date
2020-07-01
Completion date
Unknown
Last updated
2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

Experimental group:Postoperative analgesia with dezocine

Sponsors

The Second Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. This study was approved by the ethics committee of the second hospital of Shandong University; 2. All patients or family members sign informed consent; 3. Patients who meet the surgical indications; 4. Patients aged 30-60 years; 5. Patients with ASA grades I to II.

Exclusion criteria

Exclusion criteria: 1. Patients with cognitive impairment before operation; 2. Patients with history of severe hypertension or heart disease; 3. Patients with severe hepatorenal insufficiency; 4. Patients with immune system diseases, endocrine system diseases, blood system diseases and abnormal coagulation; 5. Patients with acute and chronic infectious diseases; 6. Patients with distant organ metastasis; 7. Patients taking antidepressants, sedatives or analgesics recently; 8. Patients who are allergic to the drugs used in the Research Institute; 9. Patients receiving hormone or immunosuppressive therapy; 10. Patients with a recent history of radiotherapy and chemotherapy; 11. Patients who changed to open surgery during operation; 12. Patients with perioperative blood transfusion; 13. Patients who failed to complete intraoperative data collection and postoperative follow-up.

Design outcomes

Primary

MeasureTime frame
Th1 cells;Th2 cells;

Secondary

MeasureTime frame
Pain Visual Analogue Scale;

Countries

China

Contacts

Public ContactFeng Chang

The Second Hospital of Shandong University

fengc2016@126.com+86 17660085521

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026